Isagenix

Isagenix International, founded in 2002, is a prominent player in the global wellness industry, headquartered in the United States. The company has developed a comprehensive range of over 175 products that aim to enhance human health and performance with scientifically proven effectiveness. Operating in 23 key markets, including the United States, Canada, Australia, Japan, and various European countries, Isagenix leverages a network of independent distributors to expand its market reach.

In the most recent financing round, Isagenix secured a $47.50M growth equity investment on April 1, 2023. Notable investors in this round included Arbour Lane Capital Management, Cerberus Capital Management, Crescent Capital Partners, and Summit House Capital Management. This investment underscores confidence in Isagenix's business model and potential for scalability in the evolving wellness sector.